Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via &beta-adrenergic receptor-dependent activation of P38/MAPK pathway

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 889-893

  Huang, Xin Yu ^a   Wang, Hong Cheng ^a   Yuan, Zhou ^a   Huang, Jian ^b   Zheng, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

adrenergic receptor; Norepinephrine; P38 MAPK pathway; Pancreatic cancer

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE P38; NORADRENALIN; PROPRANOLOL;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NOREPINEPHRINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; RECEPTORS, ADRENERGIC, BETA;

EID: 84860543431     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11476     Document Type: Article

References (28)

1. Thaker PH, Han LY, Kamat AA, et al.: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12:939-44. (Pubitemid 44175146)
2. Lutgendorf SK, Sood AK, Antoni MH: Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol 2010; 28:4094-9.
3. Spiegel D: Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002;2:383-9.
4. Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A: The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 2007; 74:20-5.
5. Schuller HM: Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2002; 2:455-63.
6. Schuller HM: Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 2007; 39:45-63.
7. Cakir Y, Plummer HK, Tithof PK, Schuller HM: Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol 2002; 21:153-7.
8. Schuller HM, Cekanova M: NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer 2005; 49:35-45. (Pubitemid 40798091)
9. Shin VY, Wu WK, Chu KM, et al.: Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci 2007; 96:21-9. (Pubitemid 46323205)
10. Wu WK, Wong HP, Luo SW, et al.: 4-(Methylnitrosamino)-1-(3-pyridyl)-1- butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. Cancer Res 2005; 65:5272-7. (Pubitemid 40827338)
11. Guo K, Ma Q, Wang L, et al.: Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009; 22:825-30.
12. Weddle DL, Tithoff P, Williams M, Schuller HM: Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 2001; 22:473-9. (Pubitemid 32203828)
13. Yan L, Herrmann V, Hofer JK, Insel PA: beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279:C1665-74.
14. Masur K, Niggemann B, Zanker KS, Entschladen F: Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 2001; 61:2866-9. (Pubitemid 32691927)
15. Zhang D, Ma QY, Hu HT, Zhang M: beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1. Cancer Biol Ther 2010; 10:19-29.
16. Douziech N, Calvo E, Laine J, Morisset J: Activation of MAP kinases in growth responsive pancreatic cancer cells. Cell Signal 1999; 11:591-602. (Pubitemid 29255891)
17. Douziech N, Lajas A, Coulombe Z, Calvo E, Laine J, Morisset J: Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines. Endocrine 1998; 9:171-83.
18. Ehlers RA, Zhang Y, Hellmich MR, Evers BM: Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIAPaCa-2. Biochem Biophys Res Commun 2000; 269:704-8.
19. English JM, Cobb MH: Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002; 23:40-5. (Pubitemid 34135974)
20. Reiche EM, Nunes SO, Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5:617-25. (Pubitemid 39303129)
21. Andersen BL, Farrar WB, Golden-Kreutz DM, et al.: Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 2004; 22:3570-80. (Pubitemid 41103664)
22. Glaser R, Kiecolt-Glaser JK: Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005; 5:243-51. (Pubitemid 40364825)
23. Schmidt C, Kraft K: Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. Eur J Med Res 1996; 1:528-32.
24. Lara HE, Dorfman M, Venegas M, et al.: Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release. Microsc Res Tech 2002; 59:495-502. (Pubitemid 35470964)
25. Sood AK, Armaiz-Pena GN, Halder J, et al.: Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 2010; 120:1515-23.
26. Yang EV, Sood AK, Chen M, et al.: Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006; 66:10357-64. (Pubitemid 44799755)
27. Sood AK, Bhatty R, Kamat AA, et al.: Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006; 12:369-75. (Pubitemid 43166123)
28. Nilsson MB, Armaiz-Pena G, Takahashi R, et al.: Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 2007; 282:29919-26. (Pubitemid 350035290)